No Data
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
U.S. Market Movers | Conexeu Sciences (CNXU.US) Debuts on U.S. Equity Market, Opening Down Over 3.6%
Conexeu Sciences is a U.S.-based early-stage medical technology company focused on developing collagen-based regenerative medicine materials.